DYD.V. Yaroslavtsev

D.V. Yaroslavtsev

*This is an algorithmically generated author record based on publicly available information.

D.V. Yaroslavtsev has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • PROTECTIVE EFFECT OF PEGYLATED COLLAGEN HYDROLYSATE ON SKIN IN AN EXPERIMENTAL MODEL OF ACCELERATED AGING

    by O.V. Grishin, P.G. Madonov, K.I. Ershov, A.P. Nadeev, S.V. Mishenina, S.V. Pozdnyakova, G.I. Baikalov, K.I. Bakhareva, D.V. Yaroslavtsev

    Introduction. Collagen hydrolysates in the form of powders and aqueous solutions are used to slow down age-related changes in the dermal matrix. To enhance their effectiveness, the higher degrees of hydrolysis are used to form dipeptides and tripeptides, which are absorbed through the intestines and activate fibroblasts for de novo collagen synthesis. Another well-known approach based on increased bioavailability is PEGylation, or immobilization of collagen hydrolysate peptides on polyethylene oxide. Aim of the research. To compare the effectiveness of collagen hydrolysate (CH) and PEGylated collagen hydrolysate (CHpeg) in a D-galactose-induced aging model in mice. Materials and methods. Skin condition was studied on four groups of ICR mice weighing 21 ± 2 g at the age of 10 weeks. In control group 1, saline solution was administered intraperitoneally (i.p.). In groups 2, 3, and 4, the accelerated aging model was reproduced by daily i.p. administration of D-galactose (56 days). Mice in group 2 were orally administered water, mice in group 3 were given 50 mg of CH in 0.5 ml of water, and mice in group 4 were given 10 mg of CHpeg in 0.5 ml of water. Morphological assessment of changes in the rat skin was performed using light microscopy (Micromed 3 microscope). Results. In group 2, compared with group 1, the epidermis thickness was 10% less (p = 0.03), the dermis thickness was 13% less (p < 0.001), and the hypodermis thickness, on the contrary, was 1.5 times greater (p = 0.027). This confirms the effectiveness of the used aging model. When comparing between the groups, it was found that the dermis thickness in group 2 was 20% less than in group 4 (CHpeg) (p < 0.001). The epidermis in group 2 (19.1 ± 7.8 μm) was less than in group CH (35.8 ± 14.3; p < 0.001) and in the CHpeg group (47.5 ± 25.4; p < 0.001). The epidermis thickness in mice with CHpeg was greater than in mice with CH (p = 0.03). The sizes of the hypodermis in groups CH and CHpeg did not differ, but they were 2 times smaller than in group 2. Conclusion. Introducing collagen hydrolysate into the diet protects the skin from the aging process. Moreover, the effectiveness of PEGylated collagen hydrolysate is significantly higher, despite the collagen hydrolysate dose being five times lower.

  • Electron beam crosslinking of polyethylene glycol for the developing an hydrogel- and peptidomimetic-based antimicrobial drug

    by P.G. Madonov, S.V. Mishenina, E.A. Bondareva, A.N. Evstropov, D.V. Yaroslavtsev, M.S. Soldatova, D.V. Klyuev, E.M. Lyubushkina, M.A. Korolev

    Introduction. Currently, the search for alternatives to conventional antibiotics, as well as for materials that do not exert an irritating effect on the body but can serve as a depot for antimicrobial substances, is highly relevant. The idea of developing a composition of a modified polyethylene glycol-based gel and an antimicrobial peptidomimetic is consi­dered promising. Aim. To study the physico-chemical processes of electron beam crosslinking of polyethylene glycol (PEG) in order to obtain a hydrogel with required properties and develop a depot-matrix for an antimicrobial peptidomimetic based on this technology. Materials and methods. PEGs with a molecular weight of 400–40 000 Da was exposed to radiation, which involves polymer degradation and crosslinking. Their properties were studied, and a composition based on PEG and the antimicrobial peptidomimetic CAMP-1 (tripeptide H-Arg-Tbt-Arg-NH-C2H4-Ph) was developed. Results. The gel was obtained using low-molecular-weight PEG and a radiation dose of 1,5–3 Mrad or high-mole­cular-weight PEG (over 4000 Da) and a radiation dose of 0,25 Mrad. To achieve gel formation by crosslinking, we used low-molecular-weight PEG (1,500 Da) and a radiation dose of 2 Mrad. The antibacterial peptidomimetic CAMP-1 was implanted into the gel obtained without technological complexity using a rotary homogenizer. An increase in the radiation dose led to a proportional decrease in gel flowability. Conclusion. Varying the electron beam exposure parameters and PEG concentration allows to obtain hydrogels with the required properties for a depot-matrix intended to implant pharmacologically active agents. CAMP-1 is retained in a gel-like depot-matrix, and the diffusion of this peptidomimetic into the aqueous phase occurs at low intensity. Developing this technology of an antimicrobial drug makes it possible to produce prototypes of finished dosage forms for topical use.